Healthcare -
Biotechnology - NASDAQ - US
$ 358.93
-2.04 %
$ 16 B
Market Cap
15.78
P/E
UTHR - REVENUE
Revenue UTHR - United Therapeutics Corporation
2.33 B
LAST VALUE
17.51%
2 YEAR CAGR
7.41%
5 YEAR CAGR
7.62%
10 YEAR CAGR